AASS antibody (AA 37-865)
Quick Overview for AASS antibody (AA 37-865) (ABIN7874420)
Target
See all AASS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 37-865
-
Purpose
- AASS Antibody / LKR / SDH
-
Purification
- Antigen affinity purified
-
Immunogen
- Recombinant human protein (amino acids E37-N865) was used as the immunogen for the AASS antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal dilution of the AASS antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- After reconstitution, the AASS antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- AASS (Aminoadipate Semialdehyde Synthase (AASS))
-
Alternative Name
- AASS
-
Background
- Alpha-aminoadipic semialdehyde synthase (AASS), also called Lysine ketoglutarate reductase (LKR) and Saccharopine dehydrogenase (SDH) is an enzyme encoded by the AASS gene in humans and is involved in their major lysine degradation pathway. This gene encodes a bifunctional enzyme that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in this gene are associated with familial hyperlysinemia.
-
UniProt
- Q9UDR5
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-